Literature DB >> 11245421

Cytokine gene expression in neoplastic B cells from human mantle cell, follicular, and marginal zone lymphomas and in their postulated normal counterparts.

I Airoldi1, R Guglielmino, F Ghiotto, A Corcione, P Facchetti, M Truini, V Pistoia.   

Abstract

Cytokines may promote tumor growth by paracrine and/or autocrine pathways. Little information is available because malignant cells differ from their normal counterparts for the cytokine repertoire they express. Here we have investigated by reverse transcription-PCR the expression of 22 cytokine genes in neoplastic B lymphocytes from six patients with mantle cell lymphoma, 10 with follicular lymphoma, and 5 with marginal zone lymphoma and in their normal counterparts, i.e., naive, germinal center, and memory B cells, purified from tonsils. The overall profiles of cytokine gene expression in neoplastic B cells and in the corresponding normal B-cell subsets were similar, but some "holes" in the repertoire of malignant versus normal B lymphocytes were detected. Different "hole" combinations were identified consistently in mantle cell lymphoma, follicular lymphoma, and marginal zone lymphoma, thus representing molecular fingerprints of each individual lymphoma entity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11245421

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

1.  The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies.

Authors:  Irma Airoldi; Emma Di Carlo; Barbara Banelli; Lidia Moserle; Claudia Cocco; Annalisa Pezzolo; Carlo Sorrentino; Edoardo Rossi; Massimo Romani; Alberto Amadori; Vito Pistoia
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

2.  Tumor-derived autophagosomes (DRibbles) induce B cell activation in a TLR2-MyD88 dependent manner.

Authors:  Weixia Li; Meng Zhou; Hongyan Ren; Hong-Ming Hu; Liwei Lu; Meng Cao; Li-xin Wang
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.